Abu Dhabi Convenes Leading Oncologists for Annual Cancer Update

The 3rd annual Mediclinic Abu Dhabi Annual Cancer Update Conference concluded on Saturday, May 18th, 2024. The conference, held under the patronage of Sheikh Nahyan Mabarak Al Nahyan, Minister of Tolerance and Coexistence, and supported by the Department of Health-Abu Dhabi, brought together over 300 oncology professionals from across the United Arab Emirates.

The Abu Dhabi gathering served as a platform for renowned oncologists, practitioners, and advocates to exchange ideas, knowledge, and advancements in cancer care. Attendees participated in discussions on a wide range of cancer-related topics, featuring presentations by 22 specialists from the UAE and Mediclinic's partner organization, Hirslanden, Switzerland.

This year's conference underscored the UAE's commitment to providing cutting-edge healthcare to its citizens. Sheikh Nahyan Mabarak Al Nahyan remarked on the nation's dedication to prioritizing health and well-being, aligning with the guidance and support of President His Highness Sheikh Mohamed bin Zayed Al Nahyan.

A key focus of the conference was the rapid evolution of cancer treatment. Highlighting this theme, Hein van Eck, Chief Executive Officer of Mediclinic Middle East, emphasized the importance for oncology professionals to remain current on the latest developments. By staying at the forefront of medical advancements, these specialists can ensure they deliver the highest quality evidence-based care to their patients.

The conference also provided a platform to explore innovative approaches to cancer management. Discussions centered on recent breakthroughs in areas like nanotechnology, T-cell therapy, and artificial intelligence, all of which hold promise for improving patient outcomes.

The Mediclinic Abu Dhabi Annual Cancer Update Conference serves as a significant contribution to the UAE's ongoing battle against cancer. By fostering knowledge exchange and collaboration among oncology professionals, the conference plays a vital role in driving advancements in cancer prevention, detection, and treatment.

Previous Article Next Article